Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $35

Benzinga Newsdesk www.benzinga.com Positive 77.1%

Neg 0% Neu 0% Pos 77.1%

Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $30 to $35.